Please assess the completion status of the following clinical trial:

Trial Title: A Study Comparing User Experience of Different Delivery Devices for Glucagon

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~All participants (Trained Users, Participants with Diabetes \[PWDs\] and Untrained Users):~* Are able to understand the purpose and procedure of the study and to give written informed consent to show willingness to participate in the study~Trained Users only:~* Are participants who are not diagnosed with Type 1 Diabetes Mellitus (T1DM) or Type 2 Diabetes Mellitus (T2DM)~* Are close friends/relatives of a patient with T1DM or T2DM on insulin~* Have not previously administered any rescue medications (e.g. epinephrine, glucagon, narcan or seizure medications)~Untrained Users only:~* Have not been diagnosed with T1DM or T2DM, and are not a Trained User of a person with T1DM or T2DM~* Have not previously administered any rescue medications (e.g. epinephrine, glucagon, narcan or seizure medications)~Exclusion Criteria:~All participants (Trained Users, PWDs and Untrained Users):~* In the opinion of the investigator or sponsor, are unsuitable for inclusion in the study~Trained Users and Untrained Users only (i.e. the participants involved in the simulations):~* Are currently enrolled in a clinical study involving any type of medical research judged not to be scientifically or medically compatible with this study~* Are judged by the investigator as being likely to have difficulty performing the administration due to physical, cognitive and/or severe psychiatric disorder~* Are judged by the investigator as being trained or experienced in performing rescue drug administration~* Are judged by the investigator as being trained or experienced in performing high-fidelity simulations of drug administration~* Have received formal training in a medical field, and/or worked in this field within the prior 5 years; or otherwise are judged by the investigator as being trained or experienced as a first responder

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Nasal Glucagon Device (NG) (Type: EXPERIMENTAL): Empty NG device administered to a manikin during simulations of severe hypoglycaemia emergencies. No drug will be administered to humans.
- Glucagon Emergency Kit (GEK) (Type: ACTIVE_COMPARATOR): Commercially available GEK delivered intramuscularly to a manikin during simulations of severe hypoglycaemia emergencies. No drug will be administered to humans.

Based on this trial design, predict the completion outcome and termination type (if applicable).